Navigation Links
Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet
Date:9/9/2009

ODT (metoclopramide HCl) is indicated as short-term therapy for adults with symptomatic, documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy and for the relief of symptoms associated with acute and recurrent diabetic gastroparesis (diabetic gastric stasis) in adults. Therapy should not exceed 12 weeks in duration. METOZOLV ODT is contraindicated in patients with intestinal obstruction, hemorrhage, or perforation; pheochromocytoma; known sensitivity or intolerance to metoclopramide; epilepsy; or are receiving concomitant medications with extrapyramidal reactions. METOZOLV ODT should be used with caution in patients showing acute dystonic reactions, drug-induced Parkinsonism, or other extrapyramidal symptoms; neuroleptic malignant syndrome; with a prior history of depression; hypertension; congestive heart failure and ventricular arrhythmia. Patients may experience withdrawal symptoms after stopping the use of METOZOLV ODT.

In clinical studies, the most frequently reported adverse events (greater than or equal to 2% occurrence) were headache, nausea, fatigue, somnolence, and vomiting.

About Wilmington Pharmaceuticals

Wilmington Pharmaceuticals develops and out-licenses patient-friendly, fast-dissolving formulations of established medications to treat pain, cardiac conditions, and central nervous system conditions. The company engages a highly skilled alliance of experts in clinical, regulatory, manufacturing, and other key areas to achieve rapid and cost-effective approval and commercialization of its products. This unique corporate model minimizes regulatory risks while maximizing economic opportunity (www.wilmingtonpharma.com).

About Salix Pharmaceuticals

Salix Pharmaceuticals, Inc., headquartered in Morrisville, North
'/>"/>

SOURCE Wilmington Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sanford Rose Associates Opens Wilmington, N.C. Office
2. Quintiles to Open Clinical Research Office in Wilmington, NC
3. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
5. Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
6. Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
7. Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009
8. Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug-Resistant Influenza at 2009 ICAAC Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... on the development and commercialization of a once-daily, oral ... gallstones, today announced financial results for the period ended ... Summary: , Reported cash and cash equivalents totaling ... at December 31, 2013.  , Reported a net ...
(Date:7/25/2014)... , July 25, 2014 Sinovac Biotech Ltd. (Nasdaq: ... in China , today announced that it ... ended June 30, 2014, after market close on Thursday, August ... prior to the market opening on Friday, August 15, 2014, ... p.m. China Standard Time) to review the Company,s financial results ...
(Date:7/24/2014)... Gain recognition for leadership and ... the biotech industry. Nominations are now being accepted ... you by the Bio Supply Management Alliance ... management professionals for the past 7 years. , ... Biotech industry – Manufacturers, Service Providers, Material Suppliers, ...
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, ... Colorado with University College Hospital (UCH) Ibadan ... development project to finance, design, construct, and operate and ... Nigeria . Under the first of the ... scoping documents and funding applications. UCH Ibadan intends to ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
... industry reveal powerful effects of, recombinant lactoferrin (tradename: ... leading to ... Oct. 10 A recently published study,in the scientific ... lactoferrin (tradename: Lacromin, see, http://www.Lacromin.com ) is a strong ...
... Oct. 10 Boston Scientific,Corporation (NYSE: BSX ... the,U.S. Food and Drug Administration (FDA) to market ... Company,plans to launch the TAXUS Liberte stent early ... the introduction of its TAXUS(R),Expresss2(TM) Atom(TM) Paclitaxel-Eluting Coronary ...
... CA, Oct. 10, 2008 Senomyx, Inc.,(Nasdaq: ... proprietary technologies,to discover and develop novel flavor ingredients ... today that Senomyx Scientific Founder,University of California, San ... Y. Tsien, Ph.D., has been awarded the Nobel,Prize ...
Cached Biology Technology:New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY 2
(Date:7/25/2014)... central nervous system disease that is caused by ... the embryonic phase. Many patients have varying degrees ... retardation. Such problems decrease the patients, functional independence ... Physical Medicine and Rehabilitation Education and Research Hospital, ... SB, using the Pediatric Evaluation of Disability Inventory ...
(Date:7/25/2014)... an unknown interaction between microorganisms and salt. When ... of salt water and is left to dry, bacteria ... 3D morphologically complex formations, where they hibernate. Afterwards, simply ... was made by chance with a home microscope, but ... journal and may help to find signs of life ...
(Date:7/24/2014)... -- The Geneva Healthcare Suite, an innovative technology platform ... room wait times by an average of 92 minutes ... to a recent study published in the Academic Emergency ... suite to access data from incoming patients, implanted cardiac ... Geneva,s technology platform we have been able to quickly ...
Breaking Biology News(10 mins):Bacteria manipulate salt to build shelters to hibernate 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
... yet of the heart of the translocon, a channel ... cell membrane. The process of transporting proteins across or ... every cell. , Howard Hughes Medical Institute investigator Joachim ... their detailed study of the translocon's core, called the ...
... sense light governs everything from seed germination, photosynthesis and ... for the first time, scientists have obtained a detailed ... a protein found in many species across life's plant, ... of the protein known as phytochrome, scientists can now ...
... , Chinese men are selectively switching from traditional ... dysfunction, but sticking with tradition for ailments such ... research published in Environmental Conservation. , The finding ... researchers at the advent of Viagra's commercial release ...
Cached Biology News:Zooming in on the protein-conducting channel 2Zooming in on the protein-conducting channel 3Scientists map one of biology's critical light-sensing structures 2Scientists map one of biology's critical light-sensing structures 3Viagra's hidden help for wildlife 2
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
...
...
This SMAD antibody sampler pack contains 5 Polyclonal ,SMAD antibodies....
Biology Products: